New Analysis Shows Exercise Can Alleviate Symptoms of Depression in Children and Adolescents
Reductions in depressive symptoms were greater in adolescents aged ≥13 years and in those with a mental illness and/or depression diagnosis, according to systematic review and meta-analysis.
USPSTF Draft Recommendation Targets Hypertensive Disorders of Pregnancy
All pregnant persons should have BP measured at each prenatal visit to prevent complications of hypertension disorders, says the USPSTF.
FDA Grants Zuranalone Priority Review for Major Depressive Disorder, Post-partum Depression
The novel oral agent is administered once daily for 14 days and has demonstrated rapid and sustained improvement in symptoms across trials.
Daily Dose: Fertility Treatment & Cardiometabolic Health in Offspring
Your daily dose of clinical news you may have missed.
Immunization Levels Disheartening This Flu Season, Says William Schaffner, MD
Vaccine uptake this respiratory virus season is lagging compared to previous years, says Schaffner, medical director of the National Foundation for Infectious Diseases.
6 Biologics for Severe Asthma, 3 Essential Facts on Each
For each of the 6 biologic agents FDA-approved for severe asthma, find the mechanism of action, indication, and biomarkers that predict enhanced response.
Endotypes of Severe Asthma: 5 Questions on Pathways, Biomarkers, Biologics
Check your knowledge of mechanistic features of severe asthma, specific biomarker level cut offs, and impact of comorbid disease on choice of biologic treatment.
Artificially-sweetened Beverages May Increase Risk for Urinary Incontinence in Women: New Findings
The findings come from an analysis of data related to more than 80 000 participants in the Women's Health Initiative Observational Study.
Body Weight Related to Beneficial Effects of SGLT-2 Inhibitors in Patients with Type 2 Diabetes in New Analysis
The beneficial effects of SGLT-2 inhibitors in reducing CV death and heart failure hospitalization in patients with T2D are related to body weight, suggest new data.
Daily Dose: Migraine and Pregnancy Complications
Fertility Treatment Impact on Cardiometabolic Health in Offspring Found Extremely Small
Differences in cardiometabolic health between IVF- and naturally-conceived children were small and not statistically significant in the largest study of its kind.
Eptinezumab Significantly Reduced Patient-reported Migraine Impact on HRQoL in Medication Overuse Headache and Chronic Migraine
Study participants with medication overuse headache reported quality of life improvements as early as study week 4 that were sustained at week 24.
COVID-19 Vaccines Safe and Effective in Children Aged 5-11 Years, According to New Research
Vaccination was associated with lower risks of infection, COVID-19-related illnesses, and hospitalizations due to COVID-19-related illnesses in children.
Long COVID in the US: By the Numbers
How many Americans report having long COVID symptoms? Which demographics is long COVID more prevalent in? A new analysis sheds light.
US Obesity Care Organizations Release Consensus Statement
The 6 obesity care organizations are collaborating to overcome the roadblocks to effective and equitable treatment for the ubiquitous, chronic, and deadly disease.
How to Handle Medical Misinformation in the Clinic
These tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.
Migraine History May Be a Risk Factor for Pregnancy Complications: New Findings
Among women with prepregnancy migraine diagnosis, rates of gestational hypertension and preeclampsia were 28% and 40% higher, respectively, vs women without migraine.
Black and Hispanic Americans Less Likely to Receive Treatment for Post-Stroke Complications, Large Analysis Finds
Researchers found that Black and Hispanic Americans were less likely to be treated for certain poststroke complications, such as mood and spasticity, compared to White adults.
Daily Dose: Preeclampsia and Risk of Premature Ischaemic Cardiovascular Disease
Tezepelumab FDA-approved for Self-administration by Patients with Severe Asthma
The approval offers patients the choice to administer the monoclonal antibody at home using a prefilled device or to continue to receive it in a clinical setting.